Horizon Space Acquisition II Corp. 8-K

What Happened
Horizon Space Acquisition II Corp. (HSPT) filed an 8‑K (filed Feb 6, 2026) supplementing the definitive proxy (declared effective Jan 13, 2026) for its February 12, 2026 shareholder Business Combination Meeting related to the proposed merger with SL BIO Ltd. The supplement adds two independent director nominees for the combined public company (PubCo): Joseph Levinson and Qian (Hebe) Xu. The filing also updates the expected post‑closing ownership table and reiterates meeting details (9:00 a.m. ET on Feb 12, 2026; redemption deadline 5:00 p.m. ET on Feb 10, 2026; record date Dec 29, 2025).

Key Details

• New independent director nominees: Joseph Levinson (CPA, >25 years accounting/public company experience; recent independent director roles) and Qian (Hebe) Xu (HSPT independent director since Nov 2024; >15 years in US‑China cross‑border investment banking). Neither will serve on PubCo board committees.
• Expected post‑closing share counts (assumptions): 566,591,350 PubCo Ordinary Shares (no redemption scenario) and 559,956,923 (maximum redemption scenario).
• William Wang is expected to beneficially own 333,832,129 shares (≈58.9% of voting power in the no‑redemption scenario); all directors and execs as a group: 333,852,129 shares (including Xu’s converted 20,000 founder shares).
• Proxy and registration: Form F‑4 (with the definitive proxy) was declared effective Jan 13, 2026. The supplement confirms executive compensation will follow SL Bio’s policies post‑close and that independent directors will receive cash retainers, expense reimbursement and possibly equity awards.

Why It Matters
This filing updates governance and ownership expectations for the combined company ahead of the shareholder vote. Adding Levinson (accounting/public company experience) and Xu (already on HSPT’s board) affects the makeup of PubCo’s independent directors but does not change the meeting schedule or proposals. William Wang’s large post‑closing stake (nearly 59% in the no‑redemption case) indicates concentrated voting control—an important fact for investors evaluating shareholder influence and governance after the merger. Shareholders retain the same voting and redemption deadlines and should review the definitive proxy/registration statement for full details and risks.